Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer

News provided by

Oncolytics Biotech Inc.

Sep 09, 2013, 06:30 ET